Drugs / GRANOTAPIDE
GRANOTAPIDE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00929539 | Jun 2009 → May 2010 | type 2 diabetes mellitus | Akros Pharma Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRANOTAPIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297618 ↗ |
| Known as | Granotapida | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297618 ↗ |
| Known as | JTT-130 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00929539 ↗ |
| Modality | Small molecule | — CHEMBL4297618 ↗ |